Pete Savage lab research, UChicago

Cancer Prevention and Control

Program Leaders: Andrea King, PhD, and Brandon Pierce, PhD

The overall goals of the Cancer Prevention and Control Program are to harness the intellectual capacity at UChicago to determine the environmental, genetic, psychological, biobehavioral, and economic factors underlying the etiology, risk, prevention, diagnosis, prognosis, and survivorship of cancer. Of the Program’s 37 members from 10 departments and two University Divisions (i.e., the Biological Sciences and Social Sciences), the majority are focused on local and global health disparities research, which serves as a cross-cutting theme for all programmatic goals.

The key research themes of the Cancer Prevention and Control Program include:

  • Improve understanding of cancer risk, screening and prevention by identifying the genomic, behavioral (including tobacco and alcohol use), socioeconomic, and environmental determinants;
  • Investigate the bio-behavioral, psychosocial, and environmental determinants of cancer-related health outcomes, including survivorship;
  • Determine cost-effectiveness and economic factors related to cancer diagnosis, treatment, and survivorship; and
  • Reduce local and global health disparities in cancer and other health outcomes and their modifiable determinants in the community through research and outreach efforts
  • Current Members

    Habibul Ahsan, MBBS, MMedSc
    Peter Angelos, MD, PhD
    Marc Bissonnette, MD
    Eugene Chang, MD
    Brian Chiu, PhD
    Jane Churpek, MD
    Rena Conti, PhD
    Christopher Daugherty, MD
    Harriet de Wit, PhD
    Anna Di Rienzo, PhD
    James Dignam, PhD
    William Green, PhD
    Donald Hedeker, PhD
    Tara Henderson, MD
    Dezheng Huo, MD, PhD
    Neil Hyman, MD
    Nora Jaskowiak, MD
    Yuan Ji, PhD
    Karen Kim, MD
    Andrea King, PhD
    Sonia Kupfer, MD
    Nita Lee, MD, MPH
    Yan Chun Li, PhD
    Zejuan Li, MD, PhD
    Stacy Tessler Lindau, MD
    Mark Lingen, DDS, PhD
    Daniel McGehee, PhD
    David Meltzer, MD, PhD
    Olufunmilayo Olopade, MBBS
    Aasim Padela, MD, MSc
    Joel Pekow, MD
    Brandon Pierce, PhD
    Blase Polite, MD
    Iris Romero, MD
    David Rubin, MD
    Fabrice Smieliauskas, PhD
    Irving Waxman, MD

Established by the CPC Program, the Cancer Outcomes and Policy Working Group is stimulating innovative research and affect positive change by bringing together and fostering collaborations between clinical and population researchers.

Learn More